![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM128 |
Gene summary for TMEM128 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM128 | Gene ID | 85013 |
Gene name | transmembrane protein 128 | |
Gene Alias | TMEM128 | |
Cytomap | 4p16.3 | |
Gene Type | protein-coding | GO ID | GO:0008150 | UniProtAcc | B7Z3K1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
85013 | TMEM128 | C43 | Human | Oral cavity | OSCC | 9.38e-11 | 2.96e-01 | 0.1704 |
85013 | TMEM128 | C46 | Human | Oral cavity | OSCC | 2.49e-24 | 6.05e-01 | 0.1673 |
85013 | TMEM128 | C51 | Human | Oral cavity | OSCC | 1.62e-03 | 4.16e-01 | 0.2674 |
85013 | TMEM128 | C57 | Human | Oral cavity | OSCC | 4.89e-08 | 3.25e-01 | 0.1679 |
85013 | TMEM128 | C06 | Human | Oral cavity | OSCC | 3.43e-07 | 7.54e-01 | 0.2699 |
85013 | TMEM128 | C08 | Human | Oral cavity | OSCC | 1.79e-17 | 4.45e-01 | 0.1919 |
85013 | TMEM128 | C09 | Human | Oral cavity | OSCC | 5.20e-08 | 3.12e-01 | 0.1431 |
85013 | TMEM128 | LN46 | Human | Oral cavity | OSCC | 1.38e-17 | 6.11e-01 | 0.1666 |
85013 | TMEM128 | LP15 | Human | Oral cavity | LP | 1.91e-04 | 8.21e-01 | 0.2174 |
85013 | TMEM128 | LP17 | Human | Oral cavity | LP | 1.07e-05 | 6.65e-01 | 0.2349 |
85013 | TMEM128 | SYSMH2 | Human | Oral cavity | OSCC | 5.76e-06 | 3.26e-01 | 0.2326 |
85013 | TMEM128 | SYSMH6 | Human | Oral cavity | OSCC | 2.54e-02 | 1.86e-01 | 0.1275 |
85013 | TMEM128 | male-WTA | Human | Thyroid | PTC | 4.96e-20 | 4.63e-02 | 0.1037 |
85013 | TMEM128 | PTC01 | Human | Thyroid | PTC | 1.59e-17 | 2.45e-01 | 0.1899 |
85013 | TMEM128 | PTC04 | Human | Thyroid | PTC | 2.56e-08 | 8.18e-02 | 0.1927 |
85013 | TMEM128 | PTC05 | Human | Thyroid | PTC | 8.99e-07 | 2.52e-01 | 0.2065 |
85013 | TMEM128 | PTC06 | Human | Thyroid | PTC | 9.63e-25 | 6.18e-01 | 0.2057 |
85013 | TMEM128 | PTC07 | Human | Thyroid | PTC | 3.79e-37 | 5.07e-01 | 0.2044 |
85013 | TMEM128 | ATC12 | Human | Thyroid | ATC | 4.64e-10 | 4.64e-02 | 0.34 |
85013 | TMEM128 | ATC13 | Human | Thyroid | ATC | 1.10e-14 | 2.05e-01 | 0.34 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM128 | deletion | Frame_Shift_Del | novel | c.214delN | p.Glu74LysfsTer27 | p.E74Kfs*27 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | |||
TMEM128 | SNV | Missense_Mutation | novel | c.127A>G | p.Lys43Glu | p.K43E | protein_coding | tolerated(0.08) | benign(0.359) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
TMEM128 | SNV | Missense_Mutation | c.269N>A | p.Leu90His | p.L90H | protein_coding | tolerated(0.55) | possibly_damaging(0.8) | TCGA-AA-A02J-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | ||
TMEM128 | insertion | Frame_Shift_Ins | novel | c.122_123insA | p.Glu42GlyfsTer8 | p.E42Gfs*8 | protein_coding | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |||
TMEM128 | SNV | Missense_Mutation | rs138483289 | c.404N>G | p.Asn135Ser | p.N135S | protein_coding | deleterious(0.02) | probably_damaging(0.994) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD | |
TMEM128 | SNV | Missense_Mutation | novel | c.286G>A | p.Ala96Thr | p.A96T | protein_coding | deleterious(0) | possibly_damaging(0.586) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD | |
TMEM128 | SNV | Missense_Mutation | novel | c.466N>A | p.Gly156Arg | p.G156R | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM128 | SNV | Missense_Mutation | c.481A>T | p.Ile161Phe | p.I161F | protein_coding | deleterious(0) | possibly_damaging(0.555) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
TMEM128 | SNV | Missense_Mutation | novel | c.172N>A | p.Ala58Thr | p.A58T | protein_coding | deleterious(0.04) | benign(0.043) | TCGA-EO-A3AZ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM128 | SNV | Missense_Mutation | rs759483260 | c.376N>C | p.Ser126Pro | p.S126P | protein_coding | deleterious(0.01) | benign(0.014) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |